SALIX PHARMACEUTICALS LTD Intangible Assets, Net (Excluding Goodwill)
SALIX PHARMACEUTICALS LTD had Intangible Assets, Net (Excluding Goodwill) of $1.63 billion as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2015-03-02
- 2014-12-31: Intangible Assets, Net (Excluding Goodwill) $1.63B.
- 2014-09-30: Intangible Assets, Net (Excluding Goodwill) $1.85B; Intangible Assets, Net (Excluding Goodwill) as first filed $1.91B.
- 2014-06-30: Intangible Assets, Net (Excluding Goodwill) $1.91B; Intangible Assets, Net (Excluding Goodwill) as first filed $1.97B.
- 2014-03-31: Intangible Assets, Net (Excluding Goodwill) $1.96B; Intangible Assets, Net (Excluding Goodwill) as first filed $2.02B.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2014-12-31 | $1.63B 10-K · filed 2015-03-02 | |
| 2014-09-30 | $1.85B 10-Q/A · filed 2015-03-02 | $1.91B 10-Q · filed 2014-11-07 |
| 2014-06-30 | $1.91B 10-Q/A · filed 2015-03-02 | $1.97B 10-Q · filed 2014-08-08 |
| 2014-03-31 | $1.96B 10-Q/A · filed 2015-03-02 | $2.02B 10-Q · filed 2014-05-09 |
| 2013-12-31 | $397.51M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $408.39M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $418.90M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $429.80M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $441.51M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $452.61M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $482.15M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $493.49M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $504.84M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $169.56M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $172.45M 10-Q · filed 2011-08-09 | |
| 2011-03-31 | $175.34M 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $64.58M 10-K · filed 2012-02-28 |